What if you could get one shot every few years that targeted all of the flu strains at once? That’s the goal of Duke University scientists who are working on a universal flu vaccine.
Read More
Seqirus Holly Springs held a ribbon cutting Monday morning to celebrate its expansion and new recognition for pandemic vaccine production and distribution. Last week, the U.S. government declared Seqirus, one of the largest influenza vaccine manufacturers in the world, “pandemic ready” to produce and distribute 150 million doses of...
Read More
RESEARCH TRIANGLE PARK – Seqirus hopes to raise the bar on flu prevention with the accelerated development of its next-generation influenza vaccine technology, called self-amplifying messenger RNA – or sa-mRNA. The Summit, New Jersey-based company is one of the largest flu vaccine manufacturers in the world. It operates a massive...
Read More
With most of the world currently focused on the rapid spread of the Delta variant of COVID-19, we shouldn’t forget that flu season also is just around the corner.
Read More
Although most of us currently are consumed by the COVID-19 coronavirus, it’s also the season to be thinking about the flu. Seqirus isn’t and touts its vaccine data.
Read More
While the world’s leading infectious disease experts consider whether the coronavirus that originated in Wuhan, China, could become the next pandemic, a Holly Springs company is working on a vaccine to protect humans from another deadly virus.
Read More
Local dignitaries are expected to attend a groundbreaking Friday as part of a ceremony by Seqirus, which is scheduled to break ground on a $140 million expansion of its plant in Holly Springs.
Read More
Seqirus, the second-largest manufacturer of flu vaccine in the world, plans to expand production at its Holly Springs plant.
Read MoreRecent research from North Carolina State University outlines how near-infrared (NIR) spectroscopy could be used to make cell-culture-based flu vaccine manufacturing faster and more efficient.
Read More
